Weber J M, Wierman C K, Hutchinson C R
J Bacteriol. 1985 Oct;164(1):425-33. doi: 10.1128/jb.164.1.425-433.1985.
Streptomyces erythreus produces the 14-membered macrolide antibiotic erythromycin A. The properties of erythromycin A nonproducing mutants and their genetic linkage to chromosomal markers were used to establish the rudiments of genetic organization of antibiotic production. Thirty-three Ery- mutants, produced by mutagenesis of S. erythreus NRRL 2338 and affecting the formation of the macrolactone and deoxysugar intermediates of erythromycin A biosynthesis, were classified into four phenotypically different groups based on their cosynthesis behavior, the type of biosynthetic intermediate accumulated, and their ability to biotransform known biochemical intermediates of erythromycin A. Demonstration of the occurrence of natural genetic recombination during conjugal mating in S. erythreus enabled comparison of the genetic linkage relationships of three different ery mutations with seven other markers on a simple chromosome map. This established a chromosomal location for the ery mutations, which appear to be located in at least two positions within one interval of the map.
红色链霉菌产生14元大环内酯类抗生素红霉素A。利用不产生红霉素A的突变体的特性及其与染色体标记的遗传连锁关系,建立了抗生素生产遗传组织的基本框架。通过对红色链霉菌NRRL 2338进行诱变产生的33个Ery-突变体,影响红霉素A生物合成中大内脂和脱氧糖中间体的形成,根据它们的共合成行为、积累的生物合成中间体类型以及它们对红霉素A已知生化中间体进行生物转化的能力,分为四个表型不同的组。在红色链霉菌的接合交配过程中自然遗传重组的发生证明,能够在一个简单的染色体图谱上比较三种不同ery突变与其他七个标记的遗传连锁关系。这确定了ery突变的染色体位置,这些突变似乎位于图谱一个区间内的至少两个位置。